PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes

Fangliang Zhang(Wuhan University), Liang Chen(Wuhan University)
British Journal of Cancer
May 28, 2024
Cited by 3


Related Papers

No related papers found

Powered by citation graph analysis